Vanda’s Tasimelteon: A Safe, Efficacious Drug In Search Of An Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA reviewers seem positive, but advisory committee will consider whether Non-24 is bona fide sleep disorder with identifiable patients.